Zoetis ZTS
NYSE ZTS
$75.50 -1.18 (-1.54%)
At close: Aug 20, 2026 · 1:49 PM UTC

Zoetis (ZTS) Acquisitions (2015 - 2022)

Zoetis (ZTS) posted quarterly Acquisitions of $215.0 million for Q3 2022, down 88.59% quarter-over-quarter from $1.9 billion in Q3 2018.

Zoetis (ZTS) Acquisitions (2015 - 2022) Analysis & Trends

Zoetis (ZTS) has reported Acquisitions for 5 consecutive years, with $215.0 million the latest figure, recorded in Q3 2022.

  • In Q3 2022, Acquisitions changed N/A year-over-year to $215.0 million; the TTM figure through Sep 2022 stood at $215.0 million (changed N/A YoY), while the FY2018 annual figure was $1.9 billion, changed N/A from the prior year.
  • Acquisitions fell to $215.0 million in Q3 2022 per ZTS's latest filing, from $1.9 billion in the prior quarter.
  • Across five years, Acquisitions topped out at $1.9 billion in Q3 2018 and bottomed at $215.0 million in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Haleon 43.89 Bn 42.93 Bn - -
2 Teva Pharmaceutical Industries 43.01 Bn 39.35 Bn 2.15 Bn -
3 Zoetis 31.52 Bn 29.84 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn -
5 United Therapeutics 22.17 Bn 19.51 Bn 683.80 Mn -
6 Viatris 18.73 Bn 17.85 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.51 Bn 15.12 Bn 935.80 Mn -
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.12 Bn 9.96 Bn - -
10 Alkermes 8.12 Bn 7.46 Bn 397.90 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2022 215.00 Mn
Sep 30, 2018 1.88 Bn
Oct 1, 2017 -3.00 Mn
Apr 2, 2017 3.00 Mn
Oct 2, 2016 68.00 Mn
Jul 3, 2016 8.00 Mn
Apr 3, 2016 12.00 Mn
Dec 31, 2015 654.00 Mn
Jun 28, 2015 -1.00 Mn
Mar 29, 2015 230.00 Mn